9 July 2015 SATVI researcher presents research at Cytometry Conference
A recent poster presentation by SATVI Postdoctoral Fellow, Virginie Rozot has demonstrated that the CyTOF is a powerful tool that allows unbiased characterisation of the complex immune response to Mycobacterium tuberculosis. She presented her research at the 30th Congress of International Society for Advancement of Cytometry which took place in Glasgow, Scotland from 26 to 30 June 2015. Click here to download the poster presentation.
In October 2013, the South African Tuberculosis Vaccine Initiative (SATVI) took ownership of a new CyTOF®2 Mass Cytometer, funded primarily through a Clinical Infectious Diseases Research Initiative equipment award (CIDRI, in the IDM), with co-funding from the Department of Science and Technology and the Bill & Melinda Gates Foundation, USA.
Mass cytometry resolves multiple metal probes per cell with minimal signal overlap, maximizing the information obtained from a single sample, providing researchers with an unparalleled ability to phenotypically and functionally profile cells from normal and diseased states. With more than 120 detection channels, the CyTOF®2 Mass Cytometer allows simultaneous detection of up to 44 metal based antibodies for multi-parameter high content single cell analysis.